Ligand Pharmaceuticals Inc.
$232.09
USD
Last updated on --.
24h volume153.57K
24h highest237.15 USD
24h lowest229.98 USD
24h Price movement+0.06%
LGND recent prices
24 Hours
+0.06%+$0.13
30 days
+2.04%+$4.650
60 days
+16.27%+$32.47
90 days
+14.58%+$29.54
Key data
Previous close231.96 USD
Market cap4.65B USD
Volume153.57K
P/E ratio30.270000
Dividend yield (TTM)0.00%
Dividend amount0.076329 USD
Next ex-dividend dateJul 2, 2010
Next payment dateJul 1, 2010
EPS diluted (TTM)7.6600 USD
Net income (FY)153.56M USD
Revenue (FY)274.48M USD
Last report dateMay 8, 2026
About Ligand Pharmaceuticals Inc.
HeadquartersSAN DIEGO
Employees (FY)47.00
Revenue per employee (FY)5.84M USD
Net income per employee (FY)3.27M USD
Listed onNasdaq
LGND conversion tables
 |  |
|---|---|
| 0.5 LGND | 116.04 USD |
| 1 LGND | 232.09 USD |
| 5 LGND | 1,160.45 USD |
| 10 LGND | 2,320.9 USD |
| |
|---|---|
| 0.5 USD | 0.0021543 LGND |
| 1 USD | 0.0043087 LGND |
| 5 USD | 0.021543 LGND |
| 10 USD | 0.043087 LGND |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LGND is trading at $232.09, +0.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LGND stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LGND is currently trading at $232.09, +0.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LGND price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LGND's P/E ratio is currently 30.270000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LGND; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LGND's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Ligand Pharmaceuticals Inc.'s market cap is currently 4.65B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume153.57K
24h highest237.15 USD
24h lowest229.98 USD
24h Price movement+0.06%
Start trade with LGND Perpetual
Sign up to trade